Skip to main content
Earnings Labs
Relmada Therapeutics, Inc. logo

Relmada Therapeutics, Inc. (RLMD) Earnings

NASDAQ·Healthcare·Biotechnology

$3.27

+1.87%

Mkt Cap $358.41M

EPS — Estimate vs Actual

Mkt Cap

$358.41M

P/E

—

Fwd P/E

—

P/S

—

Rev TTM

—

EPS TTM

-$1.11